3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Lymphoid
2
Conditions
Carcinoma, Non-Small-Cell Lung
211
Lung Neoplasms
77
Triple Negative Breast Neoplasms
67
Breast Neoplasms
67
Ovarian Neoplasms
53
Squamous Cell Carcinoma of Head and Neck
49
Small Cell Lung Carcinoma
47
Fallopian Tube Neoplasms
34
Endometrial Neoplasms
34
Neoplasms
31
Parkinson Disease 4, Autosomal Dominant Lewy Body
28
Neoplasm Metastasis
28
Head and Neck Neoplasms
24
Prostatic Neoplasms
20
Esophageal Neoplasms
18
Carcinoma
18
Urinary Bladder Neoplasms
16
Colorectal Neoplasms
16
Uterine Cervical Neoplasms
14
Oropharyngeal Neoplasms
14
Carcinoma, Transitional Cell
14
Carcinoma, Squamous Cell
14
Esophageal Squamous Cell Carcinoma
12
Brain Neoplasms
12
Stomach Neoplasms
10
Pancreatic Neoplasms
10
Lymphoma, Large B-Cell, Diffuse
10
Mouth Neoplasms
9
Laryngeal Neoplasms
9
Advanced Solid Tumors
9
Interventions
Rituximab
53
Cyclophosphamide
50
Lenalidomide
41
fludarabine
24
obinutuzumab
23
Prednisone
19
Bendamustine Hydrochloride
19
Magnetic Resonance Spectroscopy
18
Vincristine
17
Doxorubicin
16
fludarabine phosphate
15
Specimen Handling
15
zanubrutinib
13
Biopsy
12
tazemetostat
10
ibrutinib
10
Whole-Body Irradiation
10
pembrolizumab
9
Peripheral Blood Stem Cell Transplantation
9
venetoclax
8
Mycophenolic Acid
7
Etoposide
7
axicabtagene ciloleucel
6
Radiotherapy
6
CT-P10
6
Therapeutics
5
R-CHOP protocol
5
tafasitamab
4
polatuzumab vedotin
4
acalabrutinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
Carboplatin
×
1 year
×
Clear all
NCT04663347
2026-06-02
EPCOREâ„¢ NHL-2
Genmab
Phase 1/2
Active not recruiting
543 enrolled
NCT02393157
2025-08-08
O-ICE
New York Medical College
Phase 2
Recruiting
25 enrolled